Ingrid Louw

843 total citations
16 papers, 167 citations indexed

About

Ingrid Louw is a scholar working on Hematology, Rheumatology and Speech and Hearing. According to data from OpenAlex, Ingrid Louw has authored 16 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Rheumatology and 6 papers in Speech and Hearing. Recurrent topics in Ingrid Louw's work include Autoimmune and Inflammatory Disorders Research (10 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Adolescent and Pediatric Healthcare (6 papers). Ingrid Louw is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (10 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Adolescent and Pediatric Healthcare (6 papers). Ingrid Louw collaborates with scholars based in United States, Belgium and Germany. Ingrid Louw's co-authors include I. Delaet, Jeffrey Kaine, Charles Ludivico, Miranda Pans, Ingrid Strusberg, R. Pappu, Sheila Gujrathi, Patrick Durez, Bhaskar Dasgupta and Cristiano A. F. Zerbini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Ingrid Louw

15 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Louw United States 6 125 63 53 38 29 16 167
Brigitte Krummel-Lorenz Germany 3 153 1.2× 52 0.8× 59 1.1× 53 1.4× 51 1.8× 3 216
M. Cutolo Italy 3 190 1.5× 86 1.4× 38 0.7× 40 1.1× 48 1.7× 4 218
Maura Couto Portugal 7 128 1.0× 27 0.4× 145 2.7× 12 0.3× 27 0.9× 20 230
Tuulikki Sokka‐Isler Finland 7 84 0.7× 38 0.6× 49 0.9× 39 1.0× 32 1.1× 17 157
Marian H. van Beers-Tas Netherlands 9 197 1.6× 52 0.8× 43 0.8× 23 0.6× 33 1.1× 13 247
Daniel Pereira Canada 10 145 1.2× 49 0.8× 136 2.6× 16 0.4× 22 0.8× 26 249
Andrés Ponce Spain 7 85 0.7× 23 0.4× 38 0.7× 26 0.7× 12 0.4× 26 164
Peigen He China 6 86 0.7× 30 0.5× 48 0.9× 17 0.4× 17 0.6× 8 147
Suguru Honda Japan 8 100 0.8× 29 0.5× 22 0.4× 32 0.8× 35 1.2× 14 170
Lourdes P. Sejismundo United States 2 72 0.6× 14 0.2× 41 0.8× 40 1.1× 19 0.7× 3 157

Countries citing papers authored by Ingrid Louw

Since Specialization
Citations

This map shows the geographic impact of Ingrid Louw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Louw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Louw more than expected).

Fields of papers citing papers by Ingrid Louw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Louw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Louw. The network helps show where Ingrid Louw may publish in the future.

Co-authorship network of co-authors of Ingrid Louw

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Louw. A scholar is included among the top collaborators of Ingrid Louw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Louw. Ingrid Louw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Brunner, Hermine I., Nikolay Tzaribachev, Ingrid Louw, et al.. (2023). Long‐Term Maintenance of Clinical Responses by Individual Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Abatacept. Arthritis Care & Research. 75(11). 2259–2266. 1 indexed citations
3.
Ruperto, Nicolino, Hermine I. Brunner, Nikolay Tzaribachev, et al.. (2021). Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 48(7). 1073–1081. 4 indexed citations
4.
Uthman, Imad, Hani Almoallim, Christopher D. Buckley, et al.. (2020). Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East. Rheumatology International. 41(3). 529–542. 12 indexed citations
5.
6.
Louw, Ingrid, Theresa M. Williams, Jean‐Claude Becker, et al.. (2018). A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis. SHILAP Revista de lepidopterología. 6(1). 23–28. 1 indexed citations
7.
8.
9.
O’Dell, James R., Alan Kivitz, Tsutomu Takeuchi, et al.. (2017). SAT0162 Switching from etanercept to CHS-0214: a one year, randomized, double-blind study in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 76. 831–831. 3 indexed citations
10.
Vastesaeger, Nathan, Howard Amital, Karel Pavelká, et al.. (2016). Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab. Lara D. Veeken. 55(8). 1466–1476. 18 indexed citations
11.
O’Dell, James R., Tsutomu Takeuchi, Yoshiya Tanaka, et al.. (2016). OP0226 Randomized, Double-Blind Study Comparing Chs-0214 with Etanercept in Patients with Active Rheumatoid Arthritis (RA) despite Methotrexate (MTX) Therapy. Annals of the Rheumatic Diseases. 75. 143–143. 12 indexed citations
12.
13.
Dasgupta, Bhaskar, Bernard Combe, Patrick Durez, et al.. (2014). THU0155 Predictors of Low Disease Activity and Remission after One Dose of Golimumab in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 73. 233–234. 2 indexed citations
14.
Dasgupta, Bhaskar, Bernard Combe, Ingrid Louw, et al.. (2014). Patient and Physician Expectations of Add‐On Treatment With Golimumab for Rheumatoid Arthritis: Relationships Between Expectations and Clinical and Quality of Life Outcomes. Arthritis Care & Research. 66(12). 1799–1807. 13 indexed citations
15.
Combe, Bernard, Bhaskar Dasgupta, Ingrid Louw, et al.. (2013). Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study. Annals of the Rheumatic Diseases. 73(8). 1477–1486. 27 indexed citations
16.
Kaine, Jeffrey, Ingrid Strusberg, Ingrid Louw, et al.. (2011). Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). Annals of the Rheumatic Diseases. 71(1). 38–44. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brigitte Krummel-Lorenz Breakdown of academic impact, for papers by M. Cutolo Breakdown of academic impact, for papers by Maura Couto Breakdown of academic impact, for papers by Tuulikki Sokka‐Isler Breakdown of academic impact, for papers by Marian H. van Beers-Tas Breakdown of academic impact, for papers by Daniel Pereira Breakdown of academic impact, for papers by Andrés Ponce Breakdown of academic impact, for papers by Peigen He Breakdown of academic impact, for papers by Suguru Honda Breakdown of academic impact, for papers by Lourdes P. Sejismundo
Rankless by CCL
2026